L-arginine Versus Sildenafil in Children With Beta Thalassemia Associated With Pulmonary Hypertension
NCT ID: NCT03402191
Last Updated: 2018-08-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
60 participants
INTERVENTIONAL
2016-07-31
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sildenafil to Improve Exercise Capacity in People With Thalassemia and Pulmonary Hypertension
NCT00872170
Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Disease
NCT00492531
Population Pharmacokinetics and Dosage Individualization of Oral Pulmonary Vasodilators in PPHN
NCT04379180
The Assessment of Right Ventricular Contractility in Response to Sildenafil
NCT00742014
A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In Children
NCT00159874
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
L-arginine
l-arginine for pulmonary hypertension in patients with thalassemia.
L-arginine
l-arginine for thalassemia with pulmonary hypertension
Sildenafil
Sildenafil for pulmonary hypertension in patients with thalassemia.
Sildenafil
Sildenafil for thalassemia with pulmonary hypertension
Control
No pulmonary hypertension
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
L-arginine
l-arginine for thalassemia with pulmonary hypertension
Sildenafil
Sildenafil for thalassemia with pulmonary hypertension
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Other comorbid disease
6 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sherief Abd-Elsalam
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sherief Abd-Elsalam
PhDTropical Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sahar El-Haggar, Prof
Role: PRINCIPAL_INVESTIGATOR
Tanta University - Faculty of Pharmacy
Mohamed El-Shanshoury, Prof
Role: STUDY_DIRECTOR
Tanta University Pediatrics Department
Osama Abd-rab El-Rasol, Prof
Role: STUDY_CHAIR
Tanta University Pediatrics Department
Tarek Mostafa, Ass Prof
Role: STUDY_CHAIR
Tanta University-Faculty of pharmacy
Eman El-Khateeb, Msc
Role: STUDY_CHAIR
Tanta University-Faculty of pharmacy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sherief Abd-Elsalam
Tanta, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Prof Elshanshoury
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.